(Q44559483)

English

NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells

scientific article published in September 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells (English)

1 reference

Europe PubMed Central

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hermisson M

1

1 reference

Europe PubMed Central

4 December 2017

Weller M

2

1 reference

Europe PubMed Central

4 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

4 December 2017

Cell Death & Differentiation

1 reference

Europe PubMed Central

4 December 2017

10

1 reference

Europe PubMed Central

4 December 2017

9

1 reference

Europe PubMed Central

4 December 2017

1078-1089

1 reference

Europe PubMed Central

4 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cdd.4401269

0 references

Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Apoptosis signaling by death receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Inhibition of leucocyte motility by drugs used in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Sulfasalazine. Multiplicity of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Structure, regulation and function of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

NF-kappa B: ten years after

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Crosstalk between NF-kappaB-activating and apoptosis-inducing proteins of the TNF-receptor complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

NF-kappaB signals induce the expression of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

APO2 ligand: a novel lethal weapon against malignant glioma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

A critical role for the RelA subunit of nuclear factor kappaB in regulation of multiple immune-response genes and in Fas-induced cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

NFkappaB mediates apoptosis through transcriptional activation of Fas (CD95) in adenoviral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Effect of sulphasalazine and its metabolites on the generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Salicylates for ulcerative colitis--their mode of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

21 January 2018

CD95(APO-1/Fas)-mediated apoptosis: live and let die

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Scavenger effect of sulfasalazine, 5-aminosalicylic acid, and olsalazine on superoxide radical generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of effects of sulfasalazine and its metabolites on the metabolism of endogenous vs. exogenous arachidonic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of Arachidonic Acid Metabolism by Olsalazine and Other Aminosalicylates in Leukocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of TRAIL-induced apoptosis by transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

NF-kappa B-dependent Fas ligand expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of TRAIL and its receptors in viral hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401269

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CDD.4401269

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44559483&oldid=2028094175"